Enhanced osteoclast (OCL) activity plays a major role in the pathogenesis of osteoporosis, bone metastasis, and hypercalcemia of malignancy. Thus, identification and characterization of inhibitors of OCL activity should be clinically important. We have used an expression cloning approach to identify novel inhibitors of OCL activity that are produced by OCL and have recently identified, cloned, and produced in E. coli, osteoclast inhibitory peptide 1 (OIP-1), a factor that blocks both OCL formation and bone resorption. The factor is the human homologue of murine Sca1, a member of the Ly6 family of proteins that is expressed on hematopoietic precursors and also expressed by osteoblasts, but heretofore had no known effect on OCL activity. This factor represents a novel class of factors which inhibit OCL activity and that is both membrane-bound and also released from the cell. In this proposal, we will determine the mechanism of OCL inhibition by OIP-1/hSca1 by: (1) Assessing if the membrane-bound form as well as the extracellular form of OIP-1/hSca1 inhibits OCL formation. We will express a c-terminal truncation form of OIP-1/hSca1, label the soluble recombinant protein and determine if there is a target receptor by Scatchard binding analysis and cross-linking studies; (2) Examining the effects of E. coli-derived recombinant OIP-1/hSca1 on the growth and differentiation of the different stages of OCL development and determining the effect of OIP-1/hSca1 on OCL apoptosis; and (3) Testing OIP-1/hSca1 on OCL formation in vivo. As part of these studies, we will stably transfect Chinese Hamster Ovary (CHO) cells with an OIP-1/hSca1 cDNA expression construct and implant them into nude mice to assess the effects of continuous exposure of mammalian OIP-1/hSca1 on basal and IL-1 stimulated bone remodeling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE012603-01A1
Application #
2762371
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Sharrock, William J
Project Start
1999-04-10
Project End
2003-03-31
Budget Start
1999-04-10
Budget End
2000-03-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Shanmugarajan, Srinivasan; Beeson, Craig C; Reddy, Sakamuri V (2010) Osteoclast inhibitory peptide-1 binding to the Fc gammaRIIB inhibits osteoclast differentiation. Endocrinology 151:4389-99
Hikata, Tomohiro; Takaishi, Hironari; Takito, Jiro et al. (2009) PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood 113:2202-12
Shanmugarajan, Srinivasan; Kawanabe, Noriaki; Koide, Masanori et al. (2009) IL-12 stimulates the osteoclast inhibitory peptide-1 (OIP-1/hSca) gene expression in CD4+ T cells. J Cell Biochem 107:104-11
Goldstein, Oliver G; Hajiaghamohseni, Laela M; Amria, Shereen et al. (2008) Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immunother 57:1461-70
Shanmugarajan, Srinivasan; Youssef, Rimon F; Pati, Parmita et al. (2008) Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem 104:1500-8
Shanmugarajan, S; Irie, K; Musselwhite, C et al. (2007) Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotype. J Pathol 213:420-8
Shanmugarajan, Srinivasan; Swoboda, Kathryn J; Iannaccone, Susan T et al. (2007) Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling. J Child Neurol 22:967-73
Srinivasan, Shanmugarajan; Ito, Masahiro; Kajiya, Hiroshi et al. (2006) Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. Gene 371:16-24
Schaub, R; Dupont, B; Roodman, G D et al. (2000) Assignment of OSTF1 to human chromosome bands 12q24.1-->q24.2 by in situ hybridization. Cytogenet Cell Genet 88:87-8